MILabs launches the E-Class line of high-performance, economical PET, SPECT and, CT systems

2018-09-04T15:35:30+02:00June 8th, 2018|News|

Utrecht, The Netherlands, June 8th, 2018 Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same [...]

Scientist in the Spotlight: Dr. Stephen Russell, M.D., Ph.D., Mayo Clinic, Rochester USA    

2018-09-04T15:43:41+02:00June 6th, 2018|News|

Dr. Stephen Russell is pioneering oncolytic virotherapy as a new modality for the treatment of cancer using state-of-the-art facilities at the Mayo Clinic in Rochester, including the preclinical U-SPECT/CT imaging system from MILabs. Dr. Russell was recruited to the Mayo Clinic from the University of Cambridge, UK, in 1998 to be the Director of a new virus [...]

Technical University Munich installs MILabs’ PET/SPECT/Optical/CT for translational imaging

2018-09-04T16:03:40+02:00May 29th, 2018|News|

Garching-Munich, Germany and Utrecht, the Netherlands, May 29th, 2018 A MILabs VECTor5PET/SPECT/OI/CT system has been installed at the Chair of Pharmaceutical Radiochemistry on the TUM Campus in Garching. Under the direction of Prof. Hans-Jurgen Wester, this institute has established a broad and internationally renowned radiopharmaceutical research program, consisting of fundamental tracer development, innovative radiolabeling strategies, [...]

MILabs installs new VECTor5CT at Italian’s prestigious Veneto Institute of Oncology

2018-09-04T16:05:20+02:00April 24th, 2018|News|

Padova, Italy and Utrecht, the Netherlands, April 24th, 2018 The Istituto Oncologico Veneto (IOV) has acquired MILabs’ latest generation VECTor5CT as a key imaging tool to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes. Due to its high-resolution imaging capabilities, MILabs’ preclinical Versatile [...]

MILabs’ preclinical imaging annual sales grows again by nearly 50%

2018-09-04T16:08:31+02:00April 9th, 2018|News|

UTRECHT, THE NETHERLANDS, April 6, 2018 MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%.  “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms [...]

University of Copenhagen installs latest MILabs VECTor5CT system to further accelerate neuroscience research

2018-09-04T15:22:59+02:00February 5th, 2018|News|

Utrecht, The Netherlands, February 5, 2018   MILabs announced today that it has successfully completed the installation of its top-of-the-line multimodality PET-SPECT-CT in the laboratory of Prof. Maiken Nedergaard, M.D, D.M.Sci.  – Center for Translational Neuroscience, Division of Glial Disease and Therapeutics. Prof. Nedergaard is one of the most renowned names in neuroscience who discovered [...]

Installation of versatile Hybrid OI/CT system at Guangdong University of Technology

2018-04-25T09:57:05+02:00November 28th, 2017|News|

UTRECHT, The Netherlands, November 28, 2017 – The Institute of Biomedical and Pharmaceutical Sciences at Guangdong University of Technology in Guangzhou – China, has successfully installed a VECTor5 Hybrid OI/CT system from MILabs. This unique in vivo small animal imaging system combines three optical molecular imaging techniques - bioluminescence, fluorescence and Cherenkov luminescence – with [...]

MILabs installs PET/SPECT/OI/CT molecular imaging platform

2017-09-27T18:36:21+02:00September 26th, 2017|News|

MILabs installs first fully integrated PET/SPECT/OI/CT molecular imaging platform at Erasmus MC September 26, 2017 - To advance their acclaimed oncology research, researchers at the Erasmus MC and Medical Delta in the Netherlands, have acquired a VECTor5OI/CT – the world’s only preclinical in-vivo imaging system with integrated morphological, functional and nuclear and optical molecular imaging [...]

MILabs continues its record-setting pace of preclinical imaging sales

2017-08-10T12:46:23+02:00August 10th, 2017|News|

UTRECHT, THE NETHERLANDS, August 10, 2017 With three more orders booked in the third week of July, demand for MILabs' preclinical molecular imaging products into the second half of the year is continuing at record-setting first-half 2017 levels, leading the company to forecast that sales for its own manufactured products will continue to increase by [...]

University of Pennsylvania installs second MILabs system

2017-07-05T16:18:21+02:00July 5th, 2017|News|

University of Pennsylvania installs second MILabs ultra-high resolution preclinical imaging system UTRECHT, THE NETHERLANDS, July 5, 2017 The University of Pennsylvania (UPENN), Philadelphia, PA, has completed installation of its second MILabs preclinical imaging system, a scalable U-CTUHR microCT system in the lab of Prof. Joel Karp in the Department of Radiology at the University of [...]

MILabs Installs cutting-edge U-CT at National Yang-Ming University

2017-06-27T14:56:31+02:00June 27th, 2017|News|

UTRECHT, THE NETHERLANDS, June 27, 2017 MILabs installs its industry-leading microCT system at The Center of Excellence for Translational Imaging at National Yang-Ming University in Taipei of East Asia. “With the recent installation of the MILabs U-CT system, we have now access to advanced X-ray CT imaging for medical and industrial applications”, states Skye [...]

Interview with MILabs CEO at Imanis/Mayo Clinics

2017-06-26T13:33:05+02:00June 21st, 2017|News|

Imanis is excited to release a new video series showcasing our connections with leaders in the field of preclinical in vivo imaging, starting with Dr. Freek Beekman! We welcomed Dr. Freek Beekman to our offices on June 7. He was visiting Rochester, MN from his home in the Netherlands to give a presentation at [...]